Literature DB >> 12927812

Heme oxygenase-1 induction may explain the antioxidant profile of aspirin.

Nina Grosser1, Aida Abate, Stefanie Oberle, Hendrik J Vreman, Phyllis A Dennery, Jan C Becker, Thorsten Pohle, Daniel S Seidman, Henning Schröder.   

Abstract

Aspirin is known to exert antioxidant effects by as yet unidentified mechanisms. In cultured endothelial cells derived from human umbilical vein, aspirin (30-300 microM) increased heme oxygenase-1 (HO-1) protein levels in a concentration-dependent fashion up to fivefold over basal levels. HO-1 induction was accompanied by a marked increase in catalytic activity of the enzyme as reflected by enhanced formation of both carbon monoxide and bilirubin. Pretreatment with aspirin or bilirubin at low micromolar concentrations protected endothelial cells from hydrogen peroxide-mediated toxicity. HO-1 induction and endothelial protection by aspirin were not mimicked by indomethacin, another inhibitor of cyclooxygenase. The nitric oxide (NO) synthase blocker L-NAME prevented aspirin-dependent HO-1 induction. These findings demonstrate that aspirin targets HO-1, presumably via NO-dependent pathways. Induction of HO-1 expression and activity may be a novel mechanism by which aspirin prevents cellular injury under inflammatory conditions and in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927812     DOI: 10.1016/s0006-291x(03)01504-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

Review 1.  Review article: carbon monoxide in gastrointestinal physiology and its potential in therapeutics.

Authors:  S J Gibbons; P-J Verhulst; A Bharucha; G Farrugia
Journal:  Aliment Pharmacol Ther       Date:  2013-08-28       Impact factor: 8.171

2.  Influence of melatonin and acetylsalicylic acid on lipid peroxidation and antioxidant enzyme activities in gastric mucosa.

Authors:  Tetsuya Mine
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 3.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

4.  Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.

Authors:  Agnieszka Loboda; Agnieszka Jazwa; Alicja Jozkowicz; Jerzy Dorosz; Jozsef Balla; Grietje Molema; Jozef Dulak
Journal:  Atherosclerosis       Date:  2006-04-18       Impact factor: 5.162

5.  Effects of melatonin or acetylsalicylic acid on gastric oxidative stress after bile duct ligation in rats.

Authors:  Alaaddin Polat; Memet Hanifi Emre
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 6.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

7.  Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Authors:  Pernette R W de Sauvage Nolting; D Meeike Kusters; Barbara A Hutten; John J P Kastelein
Journal:  J Lipid Res       Date:  2011-06-23       Impact factor: 5.922

8.  Human ortholog of a plant salicylic acid receptor found in SK-N-SH cell line.

Authors:  Hanna Skubatz; William N Howald
Journal:  Protein J       Date:  2013-12       Impact factor: 2.371

9.  Effects of aspirin & simvastatin and aspirin, simvastatin, & lipoic acid on heme oxygenase-1 in healthy human subjects.

Authors:  Adil E Bharucha; Kyoung Moo Choi; Jessica J Saw; Simon J Gibbons; Gianrico F Farrugia; David A Carlson; Alan R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2014-07-29       Impact factor: 3.598

10.  Aspirin increases nitric oxide formation in chronic stable coronary disease.

Authors:  Scott Hetzel; David DeMets; Ricky Schneider; Steven Borzak; Wendy Schneider; Victor Serebruany; Henning Schröder; Charles H Hennekens
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-03-21       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.